(Reuters) -Indian contract drugmaker Anthem Biosciences filed for a 33.95-billion-rupee ($397 million) initial public offering, draft papers showed on Tuesday, at the fag end of what has been a ...

New Delhi, Dec 31 (PTI) Anthem Biosciences on Tuesday filed preliminary papers with capital markets regulator Sebi to float a Rs 3,395-crore initial public offering. The proposed initial public ...

The Bengaluru-based pharma company is run by Ajay Bhardwaj, a former Biocon executive, who is the founder, CEO and Managing Director at Anthem Biosciences. The company was incorporated in 2006.